First Trust Nasdaq Pharmaceuticals ETF

Yield per half year: -3.24%
Industry: Health & Biotech Equities

Category	Share, %	Quantity
Healthcare	98.90146	48

Exchange	Share, %	Quantity
NASDAQ	72.92	35
New York Stock Exchange	27.08	13

Share by country

Country	Quantity	Companies
United States	43	PFIZER (share - 7.52%) AbbVie (share - 7.41%) Johnson & Johnson (share - 6.88%) Bristol-Myers (share - 6.5%) Merck & Co (share - 6.21%) United Therapeutics Corporation (share - 4.75%) Amgen (share - 4.13%) Eli Lilly and Company (share - 4.09%) Regeneron (share - 4.01%) Gilead Sciences (share - 3.92%) Vertex (share - 3.83%) Cardinal Health (share - 3.33%) Zoetis (share - 3.28%) Viatris (share - 3.24%) Biogen (share - 3.13%) Organon & Co. (share - 2.69%) Halozyme Therapeutics, Inc. (share - 1.73%) Charles River Laboratories International (share - 1.66%) Medpace Holdings, Inc. (share - 1.25%) Incyte (share - 1.08%) Exelixis (share - 0.9849%) Prestige Consumer Healthcare Inc. (share - 0.7852%) Arcellx, Inc. (share - 0.7306%) Elanco Animal Health (share - 0.7056%) Neurocrine Biosciences (share - 0.7039%) TG Therapeutics, Inc. (share - 0.6904%) Illumina (share - 0.6051%) Rhythm Pharmaceuticals, Inc. (share - 0.5909%) Exact Sciences Corporation (share - 0.5789%) Nuvalent, Inc. (share - 0.577%) Krystal Biotech, Inc. (share - 0.5437%) Kymera Therapeutics, Inc. (share - 0.54%) Ultragenyx Pharmaceutical Inc. (share - 0.5346%) Intra-Cellular Therapies, Inc. (share - 0.5207%) Sarepta Therapeutics, Inc. (share - 0.4673%) Blueprint Medicines Corporation (share - 0.4573%) Ionis Pharmaceuticals (share - 0.4446%) Viking Therapeutics, Inc. (share - 0.416%) BioMarin Pharmaceutical (share - 0.3894%) IDEAYA Biosciences, Inc. (share - 0.3712%) ACADIA Pharmaceuticals Inc. (share - 0.3323%) Beam Therapeutics Inc. (share - 0.3101%) Arvinas, Inc. (share - 0.2618%)
Ireland	3	Jazz Pharmaceuticals plc (share - 2.77%) Perrigo (share - 1.2%) Alkermes plc (share - 0.9978%)
Netherlands	1	Merus N.V. (share - 0.4929%)
Switzerland	1	CRISPR Therapeutics AG (share - 0.2763%)

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe